Press review from 07/11/08 to 10/11/08
"Healthcare, the manager doesn't last long"
(Il Sole 24 Ore: page 1 – 10 November 2008)
NHS managers lose their seats very quickly: on average their assignment lasts 3 years and 7 months. According to Cergas Bocconi's "Oasi 2008" report, from 1996 to today, 852 executives have remained in office for less than a year. But the instability continues to grow: from 2007 to 2008, the term of office fell to one month. The position of those called to manage local health authorities is more fragile compared to hospitals and greater instability in some realities such as Calabria compared to Bolzano where the leaders are sought abroad.
http://www.aboutpharma.it/notizia.asp?id=18185
The 'credit crunch' blocks the biotech industry
(la Repubblica Affari & Finanza: page 1 – 10 November 2008)
The 'credit crunch', the decline in the supply of credit following the financial crisis, is a serious problem for biotech, a sector that still does not produce income as drugs are being tested. Biotech has always had difficulty obtaining credit from banks and after the crisis investors have further decreased. David Wield, of the Economic Social Research Council, explains: "Spending money on biotech companies is now seen as too great a risk. Drug discovery depends on long-term investments with a high risk of failure and with profits far in the future." time".
http://www.aboutpharma.it/notizia.asp?id=18193
Japan: Sanofi Pasteur launches pediatric vaccine for meningitis and pneumonia
(Les Echos online – November 10, 2008)
Starting December 19, Sanofi Pasteur will launch the ActHIB pediatric vaccine in Japan for the treatment of meningitis and pneumonia. The drug, which will be distributed by Daiitchi Sankyo, protects against Haemophilus influenzae type B, which can cause meningitis or pneumonia.
http://www.aboutpharma.it/notizia.asp?id=18191
"Healthcare, Campania towards formal notice"
(Il Mattino Naples: page 29 – 10 November 2008)
According to what was reiterated by the Minister of Welfare and Health Maurizio Sacconi, after the commissioner of Health in Lazio and Abruzzo, there could also be a default for that of Campania and Calabria. Meanwhile, the Campania Region has approved the return plan in the Council, which is now being examined by the Council: the go-ahead must arrive by the end of November, otherwise silent assent will be triggered.
http://www.aboutpharma.it/notizia.asp?id=18188
"Expenditures under scrutiny with the white coats alliance"
(Il Sole 24 Ore: page 11 – 10 November 2008)
Increasingly decisive for the future of the NHS will be the construction of networks of relationships and "intercompany relationships", to make doctors and staff the most precious allies, who work alongside the manager in a more equal system. This is what the two editors of the "Oasi 2008" report, the Observatory on the functionality of healthcare companies, Eugenio Anessi Pessina of the Catholic University and Elena Cantù of Cergas-Bocconi maintain. The challenge of the manager of NHS companies will no longer be, or only, that of maintaining balance sheets. From management innovation, it will be necessary to focus on clinical governance. For example, "through the redefinition
